As an example, KRAS activates GLI1 in pancreatic cancer cells [58], an androgen receptor (AR) protects GLI3 from proteolytic cleavage [38], and HH can be activated by the mTOR/S6K1 signaling [59]. Here, AR is linked to pancreatic neoplasm.